Phospholipase A2, Group IVB (Cytosolic) (PLA2G4B) (C-Term) Peptide
Quick Overview for Phospholipase A2, Group IVB (Cytosolic) (PLA2G4B) (C-Term) Peptide (ABIN5513498)
Target
Origin
Source
Application
-
-
Protein Region
- C-Term
-
Sequence
- SFREYSAPGV RRTPEEAAAG EVNLSSSDSP YHYTKVTYSQ EDVDKLLHLT
-
Characteristics
- This is a synthetic peptide designed for use in combination with anti- PLA2G4B Antibody. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
-
-
-
-
Application Notes
- Optimal working dilution should be determined by the investigator.
-
Restrictions
- For Research Use only
-
-
-
Format
- Lyophilized
-
Reconstitution
- Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
-
Storage
- -20 °C
-
Storage Comment
- For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
-
-
- PLA2G4B (Phospholipase A2, Group IVB (Cytosolic) (PLA2G4B))
-
Background
-
This locus represents naturally-occurring readthrough transcription between the neighboring jumonji domain containing 7 (JMJD7) and phospholipase A2, group IVB (cytosolic) (PLA2G4B) genes. Readthrough transcripts encode fusion proteins that share amino acid sequence with each individual gene product, including a partial JmjC domain and downstream C2 and phospholipase A2 domains. Alternatively spliced transcript variants have been observed.
Alias Symbols: HsT16992, cPLA2-beta
Protein Size: 482 -
Gene ID
- 8681
-
NCBI Accession
- NM_001114633, NP_001108105
Target
-